COMPOSITIONS AND METHODS RELATED TO SCAVANGER PARTICLES PRIORITY CLAIM

The disclosure provides, among other things, compositions that bind to and inhibit the biological activity of soluble biomolecules, as well as pharmaceutical compositions thereof. The compositions may comprise a plurality of paiiicles that specifically bind a target, such as a soluble biomolecule or a biomolecule on the surface of a pathogen, to inhibit the target ( or pathogen) from interacting with other molecules or cells. Also provided herein are a number of applications ( e.g., therapeutic applications) in which the compositions are useful. (Fig. 1)